Wird geladen...
Dysregulation of BET Proteins in Levodopa-Induced Dyskinesia
Levodopa (L-DOPA) remains the most effective pharmacological treatment for Parkinson’s Disease (PD) but its use is limited by the development of debilitating drug-related side effects, particularly L-DOPA induced dyskinesia (LID). LID is a consequence of long-term L-DOPA use, and in model systems is...
Gespeichert in:
| Veröffentlicht in: | Neurobiol Dis |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5410664/ https://ncbi.nlm.nih.gov/pubmed/28286180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2017.03.003 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|